Clinical study on Habb-e-Asgand in the management of Rheumatoid Arthritis
- Conditions
- Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
- Registration Number
- CTRI/2022/01/039602
- Lead Sponsor
- Central Council for Research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Clinically diagnosed /or serological evidence of Rheumatoid arthritis(Waja-ul-Mafasil). 2 Patients who have agreed to sign the informed consent, follow the protocol and willing to participate in clinical trial voluntarily.3 Mild to Moderate cases of Rheumatoid Arthritis.4 Have a diagnosis of Rheumatoid Arthritis (RA) as defined by American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR)2010 Criteria for the Classification of RA.
1. Uncontrolled Diabetes mellitus.
2. Hepatic or Renal insufficiency.
3. Other type of arthritis.
4. Pregnancy and lactation.
5. Any joint surgery in the previous 6 months
6. Patients with cardiovascular diseases.
7. Patients who refuse to give the written
consent for the study.
8. Severe cases of Rheumatoid Arthritis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in signs and symptoms of Rheumatoid arthritisTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Haematological, Radiological and Biochemical assessmentTimepoint: 45 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.